KMT2A and leukemia: The RUNX1 requirement for leukemias with CBFβ and MLL translocations further supports the idea that RUNX1 may actually promote the growth of many types of leukemia cells (Patel et al., 2012; Schnittger et al., 2011; Tang et al., 2009).